QuidelOrtho Corporation

QDEL

$13.95

+1.45%

N/A+$0.20

Healthcare

Medical - Specialties

NASDAQ

Active Trading

QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Year Born	Status
Joseph Busky	Chief Financial Officer	USD 2,640,789	1968	Active
Brian J. Blaser	President, Chief Executive Officer & Director	USD 2,289,960	1965	Active
Jonathan Siegrist	Executive Vice President of Research & Development and Chief Technology Officer	USD 1,291,473	1982	Active
Nathaniel Sisitsky	Chief Legal Officer & Corporate Secretary	USD 1,211,851	1974	Active
Philip McLellan	Chief Operations Officer	USD 1,022,752	1970	Active
Micah Young	Chief Financial Officer & Principal Financial Officer	—	1979	Active
Juliet C. Cunningham	Vice President of Investor Relations	—	—	Active
Lisa S. Hayes	Vice President of Global Marketing & Corporate Communications	—	—	Active
Andrew Corkum	Senior VP and Head of EMEA & LATAM	—	—	Active
Ronald Lee Bowman	Chief Human Resources Officer	—	1979	Active
Iris Lin	Head of JAPAC (Japan, ASPAC & China)	—	—	Active
Audra Jones	Senior VP & Head of North America	—	—	Active
Bryan Hanson	Executive VP of Global Portfolio Management and Marketing	—	1980	Active
Erich Wolff	Executive Vice President of Strategy & Corporate Development	—	—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-27	2025	Brian J. Blaser	President President and CEO CEO	Founder / CEO	$1.00M	$0	$8.97M	$0	$1.27M	$15.46K	$11.26M
2026-04-27	2025	Joseph M. Busky	CFO CFO	C-Level	$680.00K	$1.15M	$2.71M	$0	$795.33K	$14.46K	$5.36M
2026-04-27	2025	Michelle A. Hodges	Former Former CLO	Other	$625.00K	$533.02K	$1.12M	$575.70K	$637.25K	$15.57K	$3.51M
2026-04-27	2025	Philip D. McLellan	COO COO	C-Level	$515.00K	$100.00K	$639.44K	$359.80K	$393.82K	$13.93K	$2.02M
2026-04-27	2025	Jonathan P. Siegrist EVP of R&D and	CTO CTO	C-Level	$575.00K	$250.00K	$319.70K	$179.93K	$452.64K	$13.83K	$1.79M
2026-04-27	2024	Brian J. Blaser	President President and CEO CEO	Founder / CEO	$634.62K	$0	$13.43M	$0	$863.01K	$112.37K	$15.04M
2026-04-27	2024	Joseph M. Busky	CFO CFO	C-Level	$593.17K	$0	$3.29M	$0	$714.00K	$102.00K	$4.70M
2026-04-27	2024	Michelle A. Hodges	Former Former CLO	Other	$539.90K	$0	$1.74M	$356.36K	$656.25K	$15.70K	$3.31M
2026-04-27	2024	Jonathan P. Siegrist EVP of R&D and	CTO CTO	C-Level	$117.21K	$250.00K	$2.25M	$0	$106.68K	$742	$2.72M
2026-04-27	2024	Philip D. McLellan	COO COO	C-Level	$407.27K	$0	$579.56K	$219.88K	$405.56K	$9.94K	$1.62M
2026-04-27	2023	Joseph M. Busky	CFO CFO	C-Level	$569.25K	$230.63K	$1.29M	$760.17K	$0	$90.75K	$2.94M
2026-04-27	2023	Michelle A. Hodges	Former Former CLO	Other	$514.13K	$271.69K	$646.15K	$353.25K	$0	$15.25K	$1.80M

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of QDEL

RELATIONS

Upstream

Shenzhen Lifotronic Technology Co., Ltd.SHSE:688389Shanghai Runda Medical Technology Co., Ltd.SHSE:603108Thermo Fisher Scientific Inc.NYSE:TMOVarious single-source raw material and component suppliersAntibody and biological reagent producers (industry-level)Specialty chemical and membrane manufacturers (industry-level)

Downstream

McKesson CorporationNYSE:MCK Cardinal Health, Inc.NYSE:CAH Henry Schein, Inc.NASDAQ:HSIC Thermo Fisher Scientific / Fisher ScientificNYSE:TMOHospitals and Hospital Networks (US & global)Clinical Reference LaboratoriesBlood Banks, Plasma Centers, and Donor Screening OrganizationsRetail Pharmacies, Urgent Care Centers, and Physician Offices

Proxies

Abbott LaboratoriesNYSE:ABT Danaher CorporationNYSE:DHR Bio-Rad Laboratories, Inc.NYSE:BIOSiemens Healthineers AGETR:SHL

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer